James Hamilton
Vermogen: 18 M $ op 31-05-2026
Vermogen: 18 M $ op 31-05-2026
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. Dr. Hamilton is Chief Medical Officer, Head-Research & Development at Arrowhead Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Hamilton was Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton completed undergraduate studies at Miami University and earned an MBA and a doctorate from The Ohio State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-03-2026 | 236.958 ( 0,17% ) | 18 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Oprichter | - |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | President | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau